Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00418938
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2007-01-04
Brief Title:
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
Sponsor:
Organization:
Amgen